SPC
CLVS

Sigma Planning Corp’s Clovis Oncology, Inc. CLVS Stock Holding History

Sigma Planning Corp’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-52,148
Closed -$62K – 1356
2022
Q3 		$62K Buy
52,148
+7,650
+17% +$11.9K ﹤0.01% 1210
2022
Q2 		$80K Buy
44,498
+13,000
+41% +$19.2K ﹤0.01% 1227
2022
Q1 		$64K Buy
31,498
+18,249
+138% +$35.8K ﹤0.01% 1329
2021
Q4 		$36K Buy
+13,249
New +$49K ﹤0.01% 1366

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Sigma Planning Corp's CLVS Position: Q4 2022 in Review

Sigma Planning Corp sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 52,148 shares — an estimated $62K sold.

Sigma Planning Corp first reported a position in CLVS in Q4 2021 and held it in 4 quarters. The position peaked at $80K in Q2 2022. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Sigma Planning Corp reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Sigma Planning Corp sold 52,148 Clovis Oncology, Inc. shares in Q4 2022, an estimated $62K.
  • Sigma Planning Corp first reported a position in Clovis Oncology, Inc. in Q4 2021 and held it in 4 quarters.
  • Sigma Planning Corp's Clovis Oncology, Inc. position peaked at $80K in Q2 2022.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Sigma Planning Corp's 13F filing for Q4 2022, filed 24 Jan 2023.